Long-term follow-up and predictors of target lesion failure after implantation of everolimus-eluting bioresorbable scaffolds in real-world practice

Bioresorbable scaffolds (BRS) have been shown to be inferior to drug-eluting stents in randomized trials. Nevertheless, patients treated during daily routine differ from those treated within randomized trials and thus need further long-term evaluation. The present investigation aims to address this lack.

Source: International Journal of Cardiology - February 26, 2020 Category: Cardiology Authors: Jens Wiebe, Moritz Baquet, Oliver D örr, Petra Hoppmann, David Jochheim, Tobias Rheude, Niklas Boeder, David Grundman, Florian Blachutzik, Hans Theiss, Salvatore Cassese, Felix J. Hofmann, Sarah Gschwendtner, Albrecht Elsässer, Steffen Massberg, Christi Source Type: research